Constella 145 mcg (Linaclotide CAPSULE) 145 MCG

Constella 145 mcg capsules contain linaclotide, a medication used to manage irritable bowel syndrome with constipation (IBS-C). This prescription drug helps alleviate symptoms like abdominal pain and discomfort.

Strength

145 MCG

Manufacturer / TM Owner

ABBVIE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Constella 145 mcg capsules are primarily used for the treatment of irritable bowel syndrome with constipation (IBS-C). This medication works by targeting the underlying causes of IBS-C, such as abdominal pain and bloating. People often ask, 'What is linaclotide used for?' and the answer is that it helps manage these specific symptoms associated with IBS-C.

Side Effects

Common effects of Constella 145 mcg capsules may include diarrhea, as the medication works to relieve constipation. Some users might experience abdominal pain or discomfort as their body adjusts to the medication. These effects are generally mild and temporary.

Precautions & Warnings

Constella 145 mcg capsules should be handled with care. Store them at room temperature away from moisture and heat. Keep the medication out of reach of children and pets. Always follow the instructions provided by your healthcare professional.

Avoid Interactions

Constella 145 mcg capsules may interact with certain medications, including those that affect the digestive system. It is important to inform your healthcare provider about all the medications you are taking to avoid potential interactions. Alcohol and other substances that affect digestion should also be considered.

Frequently Asked Questions

Constella 145 mcg capsules are used to manage symptoms of irritable bowel syndrome with constipation (IBS-C), including abdominal pain and bloating.

Constella 145 mcg capsules are taken orally, typically once daily. Follow the instructions provided by your healthcare professional for the best results.

Common side effects may include diarrhea, abdominal pain, and discomfort. These effects are usually mild and temporary.

It is important to consult your healthcare provider before taking Constella 145 mcg with other medications to avoid potential interactions.

Store Constella 145 mcg capsules at room temperature away from moisture and heat. Keep them out of reach of children and pets.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.